Please wait

Exhibit 107

Filed Pursuant to Rule 424(b)(5)
Registration No. 333-264845

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

Recursion Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

Table 1 – Newly Registered Securities and Carry Forward Securities

CALCULATION OF REGISTRATION FEE

			Security Type			Security Class Title			Fee Calculation			Amount to be registered			Proposed maximum offering price per Unit			Maximum aggregate offering price			Fee Rate			Amount of registration fee
Newly Registered Securities
Fees to be Paid			Equity			Class A Common Stock, par value $0.00001 per share			457(o) and 457(r)(1)			-			-			$300,000,000			0.00011020			$33,060.00
Fees Previously Paid			-			-			-			-			-			-			-			-
Carry Forward Securities
Carry Forward Securities			-			-			-			-			-			-			-			-
			Total Offering Amounts															$300,000,000						$33,060.00
			Total Fees Previously Paid																					-
			Total Fee Offsets																					-
			Net Fee Due																					$33,060.00

(1)    In accordance with Rules 465(b) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form S-3ASR (File No. 333-264845), filed on May 10, 2022.